PIVOTAL has been awarded by ADEFAM the Special Mention Award for the Most innovative Business Project of the Year
- Dr Ibrahim Farr, Chairman & CEO and Lidia Farr, Senior VP Corporate Development & Finance of Pivotal, collected the award for innovation during the annual ceremony.
- Danah® AI & Analytics, the award-winning platform, was also recognized by the CDTI (Center for Technological Development and Innovation) and is co-financed by the European Regional Development Fund (ERDF) with the aim of promoting technological development, innovation and quality research.
ADEFAM, the Family Business Association of Madrid, recently held the seventh edition of its annual awards ceremony on the 31st March 2025.
On this occasion, PIVOTAL, a European CRO (Contract Clinical Research Organisation) with global presence and dedicated to cutting-edge clinical research into new drugs in various therapeutic areas, was awarded the prize for the most innovative business project. “It has been years of hard work and perseverance, so we are very excited about this recognition from ADEFAM,” said Lidia Farr.
Danah® AI & Analytics is an advanced platform that eliminates silos in the management of data generated in clinical trials, presents it in real time and uses Artificial Intelligence to identify and predict clinical risks in patients, anticipating decision making and increasing the safety of patients participating in clinical trials. “This project would not have been possible without the dedication and effort of the Danah® team, who have created a cutting-edge platform that is changing the way clinical trials are managed. We will continue to invest heavily in innovation as before, because innovation is not the destination, it is the way forward”, said Lidia Farr.
MEDIA CONTACT
Ms. Natalia Farr
natalia.farr@pivotalcr.com